FIELD: biotechnology.
SUBSTANCE: group of inventions is described, including a method for purifying a subtype of Factor VIII (FVIII) (embodiments), where the subtype FVIII is defined as a single FVIII heavy chain that is associated with a single FVIII light chain. In one embodiment, the method includes the steps of: (1) anion exchange chromatography with a composition comprising several FVIII subtypes and collecting the eluate fraction comprising said FVIII subtypes to be purified, (2) size exclusion chromatography of the eluate fraction obtained in step (1) comprising said FVIII subtype and collecting the eluate comprising the specified purified FVIII subtypes; and (3) concentrating the fraction of the eluate obtained in step (2) comprising said FVIII subtypes to be purified.
FIELD: invention expands the range of methods for purification of the FVIII subtypes.
12 cl, 58 dwg, 29 tbl, 29 ex
Title | Year | Author | Number |
---|---|---|---|
PREPARATION CONTAINING VIII FACTOR AND VON WILLEBRAND FACTOR PEPTIDES | 2015 |
|
RU2714154C2 |
IMPROVED FVIII FUSION PROTEIN AND ITS USE | 2019 |
|
RU2789085C2 |
HIGH GLYCATED FUSED PROTEIN BASED ON HUMAN BLOOD COAGULATION FACTOR VIII, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2016 |
|
RU2722374C1 |
PROTEIN COMPOSITIONS AGAINST VEGF AND METHODS FOR THEIR PRODUCTION | 2020 |
|
RU2795973C1 |
PROTEIN COMPOSITIONS AGAINST VEGF AND METHODS FOR THEIR PRODUCTION | 2020 |
|
RU2785994C1 |
PROTEIN COMPOSITIONS AGAINST VEGF AND METHODS FOR THEIR PREPARATION | 2020 |
|
RU2788949C1 |
PROTEIN COMPOSITIONS AGAINST VEGF AND METHODS FOR THEIR PRODUCTION | 2020 |
|
RU2778325C1 |
VERSIONS AND ISOFORMS OF ANTIBODIES WITH REDUCED BIOLOGICAL ACTIVITY | 2018 |
|
RU2813990C2 |
SEPARATION OF ANTIBODIES WITH THREE LIGHT CHAINS USING CATION EXCHANGE CHROMATOGRAPHY | 2018 |
|
RU2795432C2 |
1E10 MONOCLONAL MOUSE ANTIBODY 1E10 AND RECOMBINANT CHIMERIC (MOUSE-HUMAN) ANTIBODY XI1E10, NEUTRALIZING BACILLUS ANTHRACIS LETHAL TOXIN, AND A STRAIN OF HYBRID CULTURED ABIMAL CELLS -MUS MUSCULUS 1E10 | 2020 |
|
RU2745116C1 |
Authors
Dates
2023-07-21—Published
2018-06-22—Filed